Senior Program Officer

Emily Locke focuses on preclinical development of malaria vaccine candidates, with a particular interest in identifying assays that are predictive of protection in the field.

Prior to joining MVI, Emily spent two years as a project manager for the Biomedical Center in St. Petersburg, Russia, where she managed Johns Hopkins University’s involvement in an international effort to engage Russia in global HIV research and prevention. She also worked for five years as a structural biologist and yeast geneticist for the NIH.

She received an MPH and a PhD in biology from Johns Hopkins University.